Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: A conserved regulatory mechanism important in tumorigenesis?

Gynecologic Oncology

Volumn 124, Issue 2, 2012, Pages 340-346

  Ioffe, Yevgeniya J ^a   Chiappinelli, Katherine B ^a   Mutch, David G ^a   Zighelboim, Israel ^a   Goodfellow, Paul J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrial cancer; microRNAs; PTEN; PTENP1; Tumorigenesis

Indexed keywords

MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSEUDOGENE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WILD TYPE;

CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICRORNAS; PSEUDOGENES; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 84856000440     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.10.011     Document Type: Article

References (37)

1. ACS, Atlanta Cancer facts and figures 2010 2010 American Cancer Society, Inc.
2. P.E. Ellis, and S. Ghaem-Maghami Molecular characteristics and risk factors in endometrial cancer: what are the treatment and preventative strategies? Int J Gynecol Cancer 20 2010 1207 1216
3. M. Ray, and G. Fleming Management of advanced-stage and recurrent endometrial cancer Semin Oncol 36 2009 145 154
4. N.K. Lee Adjuvant treatment of advanced-stage endometrial cancer Clin Obstet Gynecol 54 2011 256 265
5. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, and S.I. Wang PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947 (Pubitemid 27148818)
6. P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, and A.H. Ligon Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 1997 356 362 (Pubitemid 27147102)
7. I.U. Ali, L.M. Schriml, and M. Dean Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity J Natl Cancer Inst 91 1999 1922 1932
8. D. Kong, A. Suzuki, T.-T. Zou, A. Sakurada, L.W. Kemp, and S. Wakatsuki PTEN1 is frequently mutated in primary endometrial carcinomas Nat Genet 17 1997 143 144
9. K. Podsypanina, L.H. Ellenson, A. Nemes, J. Gu, M. Tamura, and K.M. Yamada Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proc Natl Acad Sci U S A 96 1999 1563 1568 (Pubitemid 29098491)
10. T. Daikoku, L. Jackson, V. Besnard, J. Whitsett, L.H. Ellenson, and S.K. Dey Cell-specific conditional deletion of Pten in the uterus results in differential phenotypes Gynecol Oncol 122 2 2011 424 429
11. T. Daikoku, Y. Hirota, S. Tranguch, A.R. Joshi, F.J. DeMayo, and J.P. Lydon Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice Cancer Res 68 2008 5619 5627
12. S. Marchini, D. Cavalieri, R. Fruscio, E. Calura, D. Garavaglia, and I.F. Nerini Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections Lancet Oncol 12 2011 273 285
13. D.E. Cohn, M. Fabbri, N. Valeri, H. Alder, I. Ivanov, and C.G. Liu Comprehensive miRNA profiling of surgically staged endometrial cancer Am J Obstet Gynecol 202 2010 656 e1-8
14. J.W. Lee, Y.A. Park, J.J. Choi, Y.Y. Lee, C.J. Kim, and C. Choi The expression of the miRNA-200 family in endometrial endometrioid carcinoma Gynecol Oncol 120 2011 56 62
15. G.H. Fujii, A.M. Morimoto, A.E. Berson, and J.B. Bolen Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN Oncogene 18 1999 1765 1769 (Pubitemid 29137467)
16. S. Hirotsune, N. Yoshida, A. Chen, L. Garrett, F. Sugiyama, and S. Takahashi An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene Nature 423 2003 91 96 (Pubitemid 36569588)
17. A.J. Mighell, N.R. Smith, P.A. Robinson, and A.F. Markham Vertebrate pseudogenes FEBS Lett 468 2000 109 114 (Pubitemid 30110777)
18. Z. Zhang, N. Carriero, and M. Gerstein Comparative analysis of processed pseudogenes in the mouse and human genomes Trends Genet 20 2004 62 67 (Pubitemid 38121355)
19. O.H. Tam, A.A. Aravin, P. Stein, A. Girard, E.P. Murchison, and S. Cheloufi Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes Nature 453 2008 534 538 (Pubitemid 351733314)
20. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 2010 1033 1038
21. A.P. Piehler, M. Hellum, J.J. Wenzel, E. Kaminski, K.B. Haug, and P. Kierulf The human ABC transporter pseudogene family: Evidence for transcription and gene-pseudogene interference BMC Genomics 9 2008 165
22. M. Zou, E.Y. Baitei, A.S. Alzahrani, F. Al-Mohanna, N.R. Farid, and B. Meyer Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors Neoplasia 11 2009 57 65
23. M.M. Melicow, and M. Tannenbaum Endometrial carcinoma of uterus masculinus (prostatic utricle). Report of 6 cases J Urol 106 1971 892 902
24. M.M. Walther, V. Nassar, R.C. Harruff, B.B. Mann Jr. , D.P. Finnerty, and K.O. Hewen-Lowe Endometrial carcinoma of the prostatic utricle: a tumor of prostatic origin J Urol 134 1985 769 773 (Pubitemid 16247702)
25. S. Das Endometrial carcinoma of prostate Urology 27 1986 543 545
26. I. Zighelboim, A.P. Schmidt, F. Gao, P.H. Thaker, M.A. Powell, and J.S. Rader ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes J Clin Oncol 27 2009 3091 3096
27. S.A. Byron, M.G. Gartside, C.L. Wellens, M.A. Mallon, J.B. Keenan, and M.A. Powell Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation Cancer Res 68 2008 6902 6907
28. M.M. Kulkarni Digital multiplexed gene expression analysis using the NanoString nCounter system Curr Protoc Mol Biol 2011 Chapter 25:Unit 25B:10
29. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, and M. Kubista The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments Clin Chem 55 2009 611 622
30. M. Mei, D. Liu, S. Dong, S. Ingvarsson, P.J. Goodfellow, and H. Chen The MLH1-93 promoter variant influences gene expression Cancer Epidemiol 34 2010 93 95
31. L. Salmena, A. Carracedo, and P.P. Pandolfi Tenets of PTEN tumor suppression Cell 133 2008 403 414 (Pubitemid 351622014)
32. A. Alimonti, A. Carracedo, J.G. Clohessy, L.C. Trotman, C. Nardella, and A. Egia Subtle variations in Pten dose determine cancer susceptibility Nat Genet 42 2010 454 458
33. K. Sato, G. Tamura, T. Tsuchiya, Y. Endoh, K. Sakata, and T. Motoyama Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer Virchows Arch 440 2002 160 165 (Pubitemid 34169853)
34. H.B. Salvesen, N. MacDonald, A. Ryan, I.J. Jacobs, E.D. Lynch, and L.A. Akslen PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma Int J Cancer 91 2001 22 26
35. C.M. Ho, M.C. Lin, S.H. Huang, C.J. Huang, H.C. Lai, and T.Y. Chien PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas Gynecol Oncol 112 2009 307 313
36. C.J. Marsit, S. Zheng, K. Aldape, P.W. Hinds, H.H. Nelson, and J.K. Wiencke PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration Hum Pathol 36 2005 768 776 (Pubitemid 41112032)
37. J.L. Hecht, and G.L. Mutter Molecular and pathologic aspects of endometrial carcinogenesis J Clin Oncol 24 2006 4783 4791 (Pubitemid 46630943)